{
  "id": 13123013,
  "title": "Profound Medical, Telix Pharma Sign Co-Education Deal To Advance PSMA-Informed Prostate Care",
  "url": "https://urgent.news/2026/10/09/profound-medical-telix-pharma-sign-co-education-deal-to-advance-psma",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-09T12:22:26.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/profound-medical-telix-pharma-sign-co-education-deal-advance-psma-informed-prostate-care"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Friday, Profound Medical Corp. (PROF) and Telix Pharmaceuticals Limited (TLX) announced a co-education agreement to educate physicians and prostate cancer centers on the complementary roles of Telix's PSMA-PET molecular imaging technologies and Profound's MRI-guided T",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care",
        "url": "https://urgent.news/2026/10/09/profound-medical-and-telix-pharmaceuticals-enter-co-education",
        "published": "2026-10-09T11:47:15.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}